Dr. Gordon comments on cardiovascular disease & other topics
By Linda on Dec 13, 2010 in F.I.G.H.T. | comments(0)
Blood clots kill and they make today’s focus on cholesterol looks badly misguided. Many natural approaches help and add Carnitine to that list. I recently attended the Nevada Homeopathic and Integrative Medicine conference in Reno.
David Berg is an expert private consultant on blood coagulation issues. His presentation there was videotaped will be available to purchase from the association (President in Nevada is Dr Michael Gerber). David Berg made it clear that his own prostate cancer went away using heparin based therapy. He agrees with me that Coumadin is never the correct answer. He is very impressed, however, with the benefits he sees with testing by reference labs he refers his clients to and with treatment with natural products particularly Boluoke (Lumbrokinase).
I reminded the attendees that EDTA MAKES HEPARIN WORK BY MOUTH, documented in 1960, published in Nature and immediately patented by Riker. I have used this to eliminate fatal heart attacks in all my patients for well over 20 years now. It is the basis for the product Beyond Chelation Improved, as this took advantage of the $10 million in research by Dr Lester Morrison, who found a HEPARIN-LIKE action from a particular seaweed based ingredient. When I added ORAL EDTA to his institute formula, we immediately had a safe oral anticoagulant and I use this as my alternative to Coumadin or Heparin when I incorporate the essential fatty acids OMEGA 3 and PRIMROSE OIL to the garlic, ginkgo and EDTA based formula.
Of course David Berg injected Lovenex for his cancer and others might use other forms of Heparin by injection. But, the idea that fibrin is an issue in delivering local oxygen to tissues where according to the Warburg research, anaerobic metabolism supports cancer, we might expect that anything that enhances local oxygen levels in tissues could be beneficial then for any cancer. My experience in chelation and thermography has made me very aware of the need to optimize tissue oxygen levels and the ability of chelation to help that occur.
The attached article suggests that one more nutrient Carnitine may be of further use in lowering fibrinogen and even C-reactive protein levels. We know that inflammation sets the stage for hypercoagulability so this is another useful nutrient to add to my long list of documented nutrients that are useful in cancer like Vitamin C, Curcumin, Artemisinin, Quercetin alone or as found with pancreatic enzymes in Wobenzym.
Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
Excerpt:
NHIondemand.com
Date: 9/27/2010L-Carnitine Plays a Role in Preventing Cardiovascular Disease.
Cardiovascular disease or heart disease is a class of diseases that involve the heart or blood vessels (arteries and veins). There are several risk factors for cardiovascular disease that are essentially immutable. These are older age, male gender, and a family history of CVD. Additionally, three major risk factors identified include cigarette smoking, dyslipidemia (high cholesterol), and hypertension. Other identified factors associated with increased risk for cardiovascular disease include physical inactivity, sleep problems, diabetes mellitus, rheumatoid arthritis, obesity, excessive intake of alcohol, thrombotic and fibrinolytic factors, elevated homocysteine levels, certain infections and inflammation, exogenously administered estrogens and androgens, certain psychosocial factors, increased fasting glucose. and frequency of migraines. The synergism of the presence of multiple risk factors must also be considered.
L-carnitine is an amino acid that is synthesized from the amino acids lysine and methionine. Because it can be synthesized in the body, L-carnitine is usually not considered to be an essential nutrient. However, it could be classified as an essential nutrient for premature infants and other individuals who are not able to synthesize it in sufficient amounts. In addition to its use in clinical conditions, L-carnitine is used with exercise programs to reduce muscle soreness.
A study published in the journal Renal Failure investigated the effects of L-carnitine on plasma coagulation and anticoagulation. The researchers enrolled thirty-six hemodialysis patients and the patients randomly received either 1000 mg a day L-carnitine or a placebo for 12 weeks. Blood was collected at the beginning of the trial and at the end to compare changes in plasma activity. The results were the L-carnitine group experienced significant reductions in serum C-reactive protein (marker for systemic inflammation) and plasma fibrinogen (an inflammation-related coagulator) in comparison to the placebo group. The authors stated “Therefore, l-carnitine may play an effective role in preventing cardiovascular diseases in these patients.”1
1 Hakeshzadeh F, Tabibi H, Ahmadinejad M, et al. Effects of L-Carnitine supplement on plasma coagulation and anticoagulation factors in hemodialysis patients. Ren Fail. 2010;32(9):1109-14.
